United States · FDA National Drug Code directory
Inbrija
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0259-6142_ec522c79-6f5a-41f8-b3b1-78159a36f3b6
- Product NDC
- 0259-6142
- Form
- CAPSULE
- Composition / generic term
- levodopa
- Labeler
- Merz Pharmaceuticals, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20181222
- Source listing expiry
- 20271231
Source-listed ingredients
- LEVODOPA — 42 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 BLISTER PACK in 1 CARTON (0259-6142-16) / 4 CAPSULE in 1 BLISTER PACK (0259-6142-01) · 0259-6142-16
- 8 BLISTER PACK in 1 CARTON (0259-6142-32) / 4 CAPSULE in 1 BLISTER PACK (0259-6142-01) · 0259-6142-32
- 15 BLISTER PACK in 1 CARTON (0259-6142-60) / 4 CAPSULE in 1 BLISTER PACK (0259-6142-01) · 0259-6142-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →